禽流感病毒流式微球量子点探针免疫诊断新方法

采用微波法水相中合成羧基化的绿色量子点,通过羧基与禽流感单克隆抗体氨基的共价结合,制备了检测禽流感病毒的探针,并结合流式微球技术,建立了量子点生物探针流式微球免疫检测禽流感病毒的新方法.以聚苯乙烯微球为蛋白质载体,将多克隆抗体包被到荧光微球上,依次加入待测抗原和量子点生物探针,形成双抗体夹心复合物,用流式细胞仪进行检测.实验结果表明,多抗和单抗的最佳质量浓度分别为92和4 mg/L,检测禽流感病毒比双抗体夹心ELISA灵敏16倍,比FITC标记单抗检测方法灵敏4倍.对阳性尿囊液的检测与ELISA呈现良好的相关性,不与鸡传染性支气管炎病毒、鸡马力克氏病毒、新城疫病毒等发生交叉反应.     

荧光免疫夹心法分离及检测EV71病毒

基于免疫磁球分离技术,利用荧光免疫夹心法捕获,建立了一种新的EV71病毒的快速检测方法。用免疫磁球特异性捕获EV71病毒,然后用生物素化的抗体结合EV71病毒,再结合标有量子点的链霉亲和素(SA-QDs)形成复合物,采用荧光光谱法进行定量检测,C4亚型EV71病毒在2.6~7.5lg(TCID50/mL)的范围内线性关系良好(R2=0.9953),检测限为1.7lg(TCID50/mL)。该方法简便快速,灵敏度高。     

超支化聚合物作为放大信号的纳米磁性微球电化学免疫分析法

提出了一种基于超支化聚合物(HBP)固化酶标二抗作为放大信号和纳米磁球相结合的超灵敏的免疫分析新方法。首先羧基纳米磁性微球共价键合乙肝抗体(HBsAb)形成免疫磁性微球,然后与待测乙肝表面抗原(HBsAg)发生特异性结合,加入HBP标记的酶标二抗(HBPS)与结合的抗原结合发生夹心反应。在外加磁场的作用下,抗体抗原免疫复合物易从样品溶液中分离,在含有邻氨基苯酚和H2O2的底液中,快速生成具有电活性的化合物3-氨基吩呃嗪,用示差脉冲伏安法(DPV)测定响应电流,电流强度(I)与乙肝表面抗原浓度(c)在0.05～10.0μg/L范围内呈线性关系,线性回归方程为I(μA)=0.140+16.80 c(μg/L),相关系数r=0.9995,检出限达0.008μg/L,并用于实际样品的测定。     

基于免疫磁球的埃博拉病毒糖蛋白高灵敏比色检测

用免疫磁球捕获埃博拉病毒糖蛋白,与生物素化抗体形成免疫夹心复合物,然后链霉亲和素标记辣根过氧化物酶(SA-HRP)催化3,3',5,5'-四甲基联苯胺(TMB)进行显色,通过370 nm处吸光度对病毒糖蛋白进行定量。对免疫磁球进行了免疫荧光表征,通过对照实验验证方法的可靠性,并对检测条件进行了优化。结果表明,吸光度与病毒糖蛋白浓度在1.0~25.0 ng/m L内呈线性关系,检出限达到0.18 ng/m L。该方法重现性较好,特异性好,抗干扰能力强,可实现复杂样品中埃博拉病毒的检测。     

免疫磁分离技术结合阻抗测量法快速检测禽流感病毒

采用免疫磁分离和阻抗测量技术联用的方法,实现了对禽流感H5亚型病毒的特异性快速检测。将偶联生物素的H5抗体固定于链霉亲和素修饰的纳米磁珠表面,制备成免疫磁珠,用于样品中禽流感H5N1病毒的分离和浓缩。使用金叉指阵列微电极测量样品阻抗,在特征频率(100 kHz)下,阻抗模值随样品中H5N1病毒浓度增加而增大。研究了抗体浓度、免疫反应时间和磁分离时间对阻抗信号的影响,结果表明,在优化的实验条件(抗体浓度0.25 g/L、免疫反应时间60 min、磁分离时间3 min)下,纯病毒样品和拭子样品中H5N1病毒浓度分别在2!1～24HA unit/50μL和20～24HA unit/50μL范围时,病毒浓度对数值与阻抗信号值呈线性相关关系,检出限分别为0.5 HA unit/50μL和2 HA unit/50μL。     

红细胞标记抗体的电化学免疫分析

研究了红细胞标记抗体的电化学免疫分析法。用乙型肝炎单克隆抗体致敏的红细胞作双抗陕 心免疫分析的酶标二抗替代物。在免疫反应完成后，结合抗原－抗体免疫复合物上的敏化红细胞在低渗溶液中溶血，释放出血红蛋白。     

生物素化高分子涂层的制备与评价

制备了一种能固载目标蛋白质, 却没有非特异性蛋白质吸附的高分子涂层. 该涂层是可生物降解的油水两亲性的三嵌段聚合物, 即生物素偶联的聚乙二醇-聚丙交酯-聚赖氨酸共聚物. 将高分子溶解于N,N-二甲基甲酰胺中, 并涂布在预先包被了聚赖氨酸的脱脂玻片基质上, 形成高分子涂层, 在其表面包被一层由明胶和聚N-乙烯基吡咯烷酮组成的封闭剂. 使用酶标免疫分析法, 对高分子涂层表面的生物活性进行评价. 依次将辣根过氧化物酶标记的链亲和素和生物素偶联的小鼠球蛋白抗原和碱性磷酸酯酶标记的马抗小鼠抗体固载在高分子涂层表面上, 通过标记酶与底物作用生色. 分析结果表明, 经过封闭以后, 生物素化的高分子涂层表面能够排斥非特异性的蛋白质; 同时特异性蛋白质之间(如生物素和链亲和素之间、抗原和抗体之间)的相互作用依然保留, 并且固定在表面的蛋白质依然保留其生物活性. 因此生物素化的聚乙二醇-聚丙交酯-聚赖氨酸三嵌段高分子可以作为生物活性材料, 用于蛋白质固载和蛋白质分离及分析.     

气相色谱法测定不对称催化合成反应液中手性1,1-二苯基-2-丙醇含量

(S)-(+)-1,1-二苯基-2-丙醇是一种很有用的医药中间体,用它可以合成生物素,此物质广泛应用于医学各领域。近年来大量研究证实,生物素-亲和素(BAS)系统几乎可与目前研究成功的各种标记物结合。在生物素-亲和素(BAS)系统中,借助所形成的生物素-亲和素-酶复合物,追踪生物素标记的抗原或抗体,通过酶催化底物显色,可检出相应的抗体或抗原。由于抗原或抗体分子可偶联多个生物素,     

生物素-亲和素放大酶联免疫吸附法测定双酚A

建立了可用于快速、灵敏地检测双酚A的生物素-亲和素放大酶联免疫吸附测定法,测得最佳实验条件为包被抗原浓度为13.8mg/L、抗体稀释为2.4×105倍,生物素化二抗和酶标亲和素的最佳稀释倍数分别为2000倍和500倍。在优化条件下,方法的线性范围0.2~1000μg/L;最低检出限0.05μg/L。所建立的方法用于食品和唾液中双酚A含量的测定,样品处理简单,结果满意。     

生物素-亲和素体系测定雌酮

雌酮与牛血清白蛋白共价结合,合成雌酮的完全抗原。利用此抗原免疫小鼠,通过细胞融合技术制备了雌酮的单克隆抗体,经纯化表征知,抗体是IgG1型,相对分子量为164000,与固定抗的亲和常数为8.2×10^8L/mol。以生物素化的羊抗鼠免疫球蛋白及辣根过氧化物酶标记的链亲和素为标记体系,通过竞争抑制的方式测定游离的雌酮,结果表明：雌酮在10～10000pg/mL内呈线性关系。     

焦测序法检测禽流感病毒

以焦测序技术为检测平台,在研究禽流感病毒基因特性的基础上,建立一种检测禽流感病毒及确定其是否为高致病性禽流感病毒的序列测定法。首先,选择一段保守的M基因序列及一段包含裂解位点的HA基因序列为研究对象,采用聚合酶链反应(polymerase chain reaction,PCR)扩增技术初步判断其是否为禽流感病毒及病毒亚型;然后采用焦测序法检测目的片段序列;最后,对焦测序法检测序列进行分析,从基因序列上判断其是否为禽流感病毒,并进一步判断病毒的亚型以及是否为高致病性禽流感病毒。研究结果表明,当焦测序反应中三磷酸酰苷双磷酸酶(Apyrase)的浓度为1.6U/mL时,能有效抑制错误信号的产生;当Klenow的浓度为90U/mL时,可读序列长度为33个碱基。采用优化的焦测序反应体系测定了4个样本,其中1个样本被判断为H5N1亚型禽流感病毒,具有潜在的高致病性;另外3个样本为H9N2型禽流感病毒,具有低致病性。本方法具有准确、快速和实时检测等优点。     

A new method for analyzing H5N1 avian influenza virus

In this paper a novel method for phylogenetic analysis of H5N1 avian influenza virus has been proposed. At first we provide a mapping of virus protein sequence. Based on this mapping, we propose a new distance measure and make use of the corresponding similarity matrix to construct phylogenic tree without requiring multiple alignment. As an application, we construct phylogenic tree for 123 species of H5N1 avian influenza virus. The phylogeny obtained is generally consistent with evolutionary trees constructed in previous studies.     

禽流感病毒HA蛋白与人受体的分子对接

血凝素(hemagglutinin,HA)是位于禽流感病毒表面的糖蛋白。在病毒感染过程中,HA与禽类宿主细胞表面受体结合,介导病毒膜与宿主核内体膜的融合,在传染过程中发挥关键作用。自然界中的禽流感病毒处于不断演化之中,其HA的禽受体结合位点常常发生氨基酸变异。因此,当HA变异体与人受体结合能力较强时,禽流感病毒往往会发生跨种传播而感染人。为预防禽流感的跨种传播,人们迫切需要发展大规模快速检测或预测HA变异体与人受体结合亲和力的方法,以评估各种新发禽流感病毒的跨种传播能力,提前筛选出有潜在危险的病毒株。针对此问题,本研究以H7N9亚型的HA蛋白H7为研究对象,发展了一种运用分子对接的计算方法,预测HA变异体与人受体的结合亲和力。该方法的计算结果表明,H7与人受体的结合亲和力普遍弱于有较强传染人能力的H1,说明H7N9亚型病毒的跨种传播能力普遍较弱;但是,计算分析也揭示,部分新发的H7N9毒株的HA有强的人受体结合亲和力,提示在自然演化过程中,H7N9病毒有可能演化出具有较强的感染人能力的新毒株,这与2013年禽流感疫情的实际发生情况相一致。因此,本文所发展的计算方法可用于快速预测新发禽流感病毒HA与人受体的结合亲和力,为新发禽流感病毒的跨种传播风险评估提供理论依据。     

Bifunctional nanostructure of magnetic core luminescent shell and its application as solid-state electrochemiluminescence sensor material

Bifunctional nanoarchitecture has been developed by combining the magnetic iron oxide and the luminescent Ru(bpy)32+ encapsulated in silica. First, the iron oxide nanoparticles were synthesized and coated with silica, which was used to isolate the magnetic nanoparticles from the outer-shell encapsulated Ru(bpy)32+ to prevent luminescence quenching. Then onto this core an outer shell of silica containing encapsulated Ru(bpy)32+ was grown through the St?ber method. Highly luminescent Ru(bpy)32+ serves as a luminescent marker, while magnetic Fe3O4 nanoparticles allow external manipulation by a magnetic field. Since Ru(bpy)32+ is a typical electrochemiluminescence (ECL) reagent and it could still maintain such property when encapsulated in the bifunctional nanoparticle, we explored the feasibility of applying the as-prepared nanostructure to fabricating an ECL sensor; such method is simple and effective. We applied the prepared ECL sensor not only to the typical Ru(bpy)32+ co-reactant tripropylamine (TPA), but also to the practically important polyamines. Consequently, the ECL sensor shows a wide linear range, high sensitivity, and good stability.     

Structural Investigations and Binding Mechanisms of Oseltamivir Drug Resistance Conferred by the E119V Mutation in Influenza H7N9 Virus

The use of vaccinations and antiviral medications have gained popularity in the therapeutic management of avian influenza H7N9 virus lately. Antiviral medicines are more popular due to being readily available. The presence of the neuraminidase protein in the avian influenza H7N9 virus and its critical role in the cleavage of sialic acid have made it a target drug in the development of influenza virus drugs. Generally, the neuraminidase proteins have common conserved amino acid residues and any mutation that occurs around or within these conserved residues affects the susceptibility and replicability of the influenza H7N9 virus. Herein, we investigated the interatomic and intermolecular dynamic impacts of the experimentally reported E119V mutation on the oseltamivir resistance of the influenza H7N9 virus. We extensively employed molecular dynamic (MD) simulations and subsequent post-MD analyses to investigate the binding mechanisms of oseltamivir-neuraminidase wildtype and E119V mutant complexes. The results revealed that the oseltamivir-wildtype complex was more thermodynamically stable than the oseltamivir-E119V mutant complex. Oseltamivir exhibited a greater binding affinity for wildtype (−15.46 ± 0.23 kcal/mol) relative to the E119V mutant (−11.72 ± 0.21 kcal/mol). The decrease in binding affinity (−3.74 kcal/mol) was consistent with RMSD, RMSF, SASA, PCA, and hydrogen bonding profiles, confirming that the E119V mutation conferred lower conformational stability and weaker protein–ligand interactions. The findings of this oseltamivir-E119V mutation may further assist in the design of compounds to overcome E119V mutation in the treatment of influenza H7N9 virus patients.     

Interdigitated array microelectrode based impedance immunosensor for detection of avian influenza virus H5N1

Continuous outbreaks of avian influenza (AI) in recent years with increasing threat to animals and human health have warranted the urgent need for rapid detection of pathogenic AI viruses. In this study, an impedance immunosensor based on an interdigitated array (IDA) microelectrode was developed as a new application for sensitive, specific and rapid detection of avian influenza virus H5N1. Polyclonal antibodies against AI virus H5N1 surface antigen HA (Hemagglutinin) were oriented on the gold microelectrode surface through protein A. Target H5N1 viruses were then captured by the immobilized antibody, resulting in a change in the impedance of the IDA microelectrode surface. Red blood cells (RBCs) were used as biolabels for further amplification of the binding reaction of the antibody-antigen (virus). The binding of target AI H5N1 onto the antibody-modified IDA microelectrode surface was further confirmed by atomic force microscopy. The impedance immunosensor could detect the target AI H5N1 virus at a titer higher than 10³ EID₅₀/ml (EID₅₀: 50% Egg Infective Dose) within 2 h. The response of the antibody-antigen (virus) interaction was shown to be virus titer-dependent, and a linear range for the titer of H5N1 virus was found between 10³ and 10⁷ EID₅₀/ml. Equivalent circuit analysis indicated that the electron transfer resistance of the redox probe [Fe(CN)₆]^3−/4− and the double layer capacitance were responsible for the impedance change due to the protein A modification, antibody immobilization, BSA (bovine serum albumin) blocking, H5N1 viruses binding and RBCs amplification. No significant interference was observed from non-target RNA viruses such as Newcastle disease virus and Infectious Bronchitis disease virus. (The H5N1 used in the study was inactivated virus.)     

The protective effects of a d-tetra-peptide hydrogel adjuvant vaccine against H7N9 influenza virus in mice

Repeated waves of influenza virus H7N9 epidemics after 2013 have caused severe influenza in humans, with mortality reaching approximately 40%–50%. To prevent possible pandemics, the development of highly effective vaccines against influenza virus H7N9 is highly desired. In the present study, by taking advantage of the d-tetra-peptide adjuvant (G^DF^DF^DY), we reported a simple method to prepare H7N9 vaccines. Naproxen (Npx), with good anti inflammatory and broad anti-viral effects, was employed as an N-terminal capping group to construct a hydrogel precursor, Npx-G^DF^DF^DY. The hydrogel adjuvant was prepared using a routine heating cooling protocol and the final vaccine was ready after mixing with the split A/Zhejiang/DTID-ZJU01/2013 (H7N9) antigen by vortexing. Compared with the traditional Al(OH)₃ adjuvant vaccine and the split vaccine, our hydrogel adjuvant vaccine showed the best preventive effects against H7N9 infection. A mechanistic study illustrated that higher antibody responses and variations in cytokine expression might account for its increased protective effects. Our strategy demonstrated the advantages of a peptide hydrogel adjuvant in the application of vaccines against H7N9 and demonstrated its potential application in vaccines against emerging threats from other viruses.     

Impact of the R292K Mutation on Influenza A (H7N9) Virus Resistance towards Peramivir: A Molecular Dynamics Perspective

In March 2013, a novel avian influenza A (H7N9) virus emerged in China. By March 2021, it had infected more than 1500 people, raising concerns regarding its epidemic potential. Similar to the highly pathogenic H5N1 virus, the H7N9 virus causes severe pneumonia and acute respiratory distress syndrome in most patients. Moreover, genetic analysis showed that this avian H7N9 virus carries human adaptation markers in the hemagglutinin and polymerase basic 2 (PB2) genes associated with cross-species transmissibility. Clinical studies showed that a single mutation, neuraminidase (NA) R292K (N2 numbering), induces resistance to peramivir in the highly pathogenic H7N9 influenza A viruses. Therefore, to evaluate the risk for human public health and understand the possible source of drug resistance, we assessed the impact of the NA-R292K mutation on avian H7N9 virus resistance towards peramivir using various molecular dynamics approaches. We observed that the single point mutation led to a distorted peramivir orientation in the enzyme active site which, in turn, perturbed the inhibitor’s binding. The R292K mutation induced a decrease in the interaction among neighboring amino acid residues when compared to its wild-type counterpart, as shown by the high degree of fluctuations in the radius of gyration. MM/GBSA calculations revealed that the mutation caused a decrease in the drug binding affinity by 17.28 kcal/mol when compared to the that for the wild-type enzyme. The mutation caused a distortion of hydrogen bond-mediated interactions with peramivir and increased the accessibility of water molecules around the K292 mutated residue.     

Reverse genetic platform for inactivated and live-attenuated influenza vaccine

Influenza vaccine strains have been traditionally developed by annual reassortment between vaccine donor strain and the epidemic virulent strains. The classical method requires screening and genotyping of the vaccine strain among various reassortant viruses, which are usually laborious and time-consuming. Here we developed an efficient reverse genetic system to generate the 6:2 reassortant vaccine virus from cDNAs derived from the influenza RNAs. Thus, cDNAs of the two RNAs coding for surface antigens, haemagglutinin and neuraminidase from the epidemic virus and the 6 internal genes from the donor strain were transfected into cells and the infectious viruses of 6:2 defined RNA ratio were rescued. X-31 virus (a high-growth virus in embryonated eggs) and its cold-adapted strain X-31 ca were judiciously chosen as donor strains for the generation of inactivated vaccine and live-attenuated vaccine, respectively. The growth properties of these recombinant viruses in embryonated chicken eggs and MDCK cell were indistinguishable as compared to those generated by classical reassortment process. Based on the reverse genetic system, we generated 6 + 2 reassortant avian influenza vaccine strains corresponding to the A/Chicken/Korea/MS96 (H9N2) and A/Indonesia/5/2005 (H5N1). The results would serve as technical platform for the generation of both injectable inactivated vaccine and the nasal spray live attenuated vaccine for the prevention of influenza epidemics and pandemics.